Herrero Babiloni A, Baril AA, Charlebois-Plante C, Jodoin M, Sanchez E, De Baets L, et al. The putative role of neuroinflammation in the interaction between traumatic brain injuries, sleep, pain and other neuropsychiatric outcomes: a state-of-the-art review. J Clin Med. 2023;12:1793.

Baulieu EE, Robel P, Schumacher M. Neurosteroids: beginning of the story. Int Rev Neurobiol. 2001;46:1–32.

Article  CAS  PubMed  Google Scholar 

Melcangi RC, Giatti S, Garcia-Segura LM. Levels and actions of neuroactive steroids in the nervous system under physiological and pathological conditions: sex-specific features. Neurosci Biobehav Rev. 2016;67:25–40.

Article  CAS  PubMed  Google Scholar 

Reddy DS. Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res. 2010;186:113–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cameron JL. Interrelationships between hormones, behavior, and affect during adolescence: understanding hormonal, physical, and brain changes occurring in association with pubertal activation of the reproductive axis. Introduction to part III. Ann N Y Acad Sci. 2004;1021:110–23.

Chen S, Wang JM, Irwin RW, Yao J, Liu L, Brinton RD. Allopregnanolone promotes regeneration and reduces β-amyloid burden in a preclinical model of Alzheimer’s disease. PLoS ONE. 2011;6:e24293.

Dang J, Mitkari B, Kipp M, Beyer C. Gonadal steroids prevent cell damage and stimulate behavioral recovery after transient middle cerebral artery occlusion in male and female rats. Brain Behav Immun. 2011;25:715–26.

Article  CAS  PubMed  Google Scholar 

Fancy SP, Chan JR, Baranzini SE, Franklin RJ, Rowitch DH. Myelin regeneration: a recapitulation of development? Annu Rev Neurosci. 2011;34:21–43.

Article  CAS  PubMed  Google Scholar 

Liu A, Margaill I, Zhang S, Labombarda F, Coqueran B, Delespierre B, et al. Progesterone receptors: a key for neuroprotection in experimental stroke. Endocrinology. 2012;153:3747–57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Labombarda F, Pianos A, Liere P, Eychenne B, Gonzalez S, Cambourg A, et al. Injury elicited increase in spinal cord neurosteroid content analyzed by gas chromatography mass spectrometry. Endocrinology. 2006;147:1847–59.

Article  CAS  PubMed  Google Scholar 

Labombarda F, González S, Lima A, Roig P, Guennoun R, Schumacher M, et al. Progesterone attenuates astro- and microgliosis and enhances oligodendrocyte differentiation following spinal cord injury. Exp Neurol. 2011;231:135–46.

Article  CAS  PubMed  Google Scholar 

Peper JS, van den Heuvel MP, Mandl RC, Hulshoff Pol HE, van Honk J. Sex steroids and connectivity in the human brain: a review of neuroimaging studies. Psychoneuroendocrinology. 2011;36:1101–13.

Article  CAS  PubMed  Google Scholar 

De Nicola AF, Labombarda F, Gonzalez Deniselle MC, Gonzalez SL, Garay L, Meyer M, et al. Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration. Front Neuroendocrinol. 2009;30:173–87.

Article  PubMed  Google Scholar 

Meffre D, Labombarda F, Delespierre B, Chastre A, De Nicola AF, Stein DG, et al. Distribution of membrane progesterone receptor alpha in the male mouse and rat brain and its regulation after traumatic brain injury. Neuroscience. 2013;231:111–24.

Article  CAS  PubMed  Google Scholar 

Wagner AK, McCullough EH, Niyonkuru C, Ozawa H, Loucks TL, Dobos JA, et al. Acute serum hormone levels: characterization and prognosis after severe traumatic brain injury. J Neurotrauma. 2011;28:871–88.

Article  PubMed  PubMed Central  Google Scholar 

Roof RL, Duvdevani R, Stein DG. Gender influences outcome of brain injury: progesterone plays a protective role. Brain Res. 1993;607:333–6.

Article  CAS  PubMed  Google Scholar 

Schumacher M, Mattern C, Ghoumari A, Oudinet JP, Liere P, Labombarda F, et al. Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors. Prog Neurobiol. 2014;113:6–39.

Article  CAS  PubMed  Google Scholar 

He J, Evans CO, Hoffman SW, Oyesiku NM, Stein DG. Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp Neurol. 2004;189:404–12.

Article  CAS  PubMed  Google Scholar 

He J, Hoffman SW, Stein DG. Allopregnanolone, a progesterone metabolite, enhances behavioral recovery and decreases neuronal loss after traumatic brain injury. Restor Neurol Neurosci. 2004;22:19–31.

CAS  PubMed  Google Scholar 

Guennoun R. Progesterone in the brain: hormone, neurosteroid and neuroprotectant. Int J Mol Sci. 2020;21:5271.

Djebaili M, Guo Q, Pettus EH, Hoffman SW, Stein DG. The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. J Neurotrauma. 2005;22:106–18.

Article  PubMed  Google Scholar 

Djebaili M, Hoffman SW, Stein DG. Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal cortex. Neuroscience. 2004;123:349–59.

Article  CAS  PubMed  Google Scholar 

Labombarda F, Ghoumari AM, Liere P, De Nicola AF, Schumacher M, Guennoun R. Neuroprotection by steroids after neurotrauma in organotypic spinal cord cultures: a key role for progesterone receptors and steroidal modulators of GABA(A) receptors. Neuropharmacology. 2013;71:46–55.

Article  CAS  PubMed  Google Scholar 

Uchida M, Palmateer JM, Herson PS, DeVries AC, Cheng J, Hurn PD. Dose-dependent effects of androgens on outcome after focal cerebral ischemia in adult male mice. J Cereb Blood Flow Metab. 2009;29:1454–62.

Article  CAS  PubMed  Google Scholar 

VanLandingham JW, Cekic M, Cutler SM, Hoffman SW, Washington ER, Johnson SJ, et al. Progesterone and its metabolite allopregnanolone differentially regulate hemostatic proteins after traumatic brain injury. J Cereb Blood Flow Metab. 2008;28:1786–94.

Article  CAS  PubMed  Google Scholar 

Marx CE, Naylor JC, Kilts JD, Dunn CE, Tupler LA, Szabo ST, et al. Frontiers in Neuroscience Neurosteroids and traumatic brain injury: translating biomarkers to therapeutics; overview and pilot investigations in Iraq and Afghanistan era veterans. In: Laskowitz D, Grant G, editors. Translational Research in Traumatic Brain Injury. Boca Raton (FL): CRC Press/Taylor and Francis Group© 2016 by Taylor & Francis Group, LLC.; 2016. Chapter 7.

Pinna G. Allopregnanolone (1938–2019): a trajectory of 80 years of outstanding scientific achievements. Neurobiol Stress. 2020;13:100246.

Edinoff AN, Odisho AS, Lewis K, Kaskas A, Hunt G, Cornett EM, et al. Brexanolone, a GABA(A) modulator, in the treatment of postpartum depression in adults: a comprehensive review. Front Psychiatry. 2021;12:699740.

Kinzel P, Marx CE, Sollmann N, Hartl E, Guenette JP, Kaufmann D, et al. Serum neurosteroid levels are associated with cortical thickness in individuals diagnosed with posttraumatic stress disorder and history of mild traumatic brain injury. Clin EEG Neurosci. 2020;51:285–99.

Article  PubMed  Google Scholar 

Rasmusson AM, Marx CE, Pineles SL, Locci A, Scioli-Salter ER, Nillni YI, et al. Neuroactive steroids and PTSD treatment. Neurosci Lett. 2017;649:156–63.

Article  CAS  PubMed  Google Scholar 

Lamb YN. Ganaxolone: First Approval. Drugs. 2022;82:933–40.

Article  CAS  PubMed  Google Scholar 

Paul AM, Branton WG, Walsh JG, Polyak MJ, Lu JQ, Baker GB, et al. GABA transport and neuroinflammation are coupled in multiple sclerosis: regulation of the GABA transporter-2 by ganaxolone. Neuroscience. 2014;273:24–38.

Article  CAS  PubMed  Google Scholar 

Pinna G, Rasmusson AM. Ganaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorder. Front Cell Neurosci. 2014;8:256.

Article  PubMed  PubMed Central  Google Scholar 

Wright DW, Kellermann AL, Hertzberg VS, Clark PL, Frankel M, Goldstein FC, et al. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med. 2007;49(391–402):e1-2.

Google Scholar 

Xiao G, Wei J, Yan W, Wang W, Lu Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care. 2008;12:R61.

Article  PubMed  PubMed Central  Google Scholar 

Wright DW, Yeatts SD, Silbergleit R, Palesch YY, Hertzberg VS, Frankel M, et al. Very early administration of progesterone for acute traumatic brain injury. N Engl J Med. 2014;371:2457–66.

Article  PubMed  PubMed Central  Google Scholar 

Skolnick BE, Maas AI, Narayan RK, van der Hoop RG, MacAllister T, Ward JD, et al. A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med. 2014;371:2467–76.

Article  PubMed  Google Scholar 

Stein DG. Embracing failure: what the Phase III progesterone studies can teach about TBI clinical trials. Brain Inj. 2015;29:1259–72.

Article  PubMed  PubMed Central  Google Scholar 

Schumacher M, Denier C, Oudinet JP, Adams D, Guennoun R. Progesterone neuroprotection: The background of clinical trial failure. J Steroid Biochem Mol Biol. 2016;160:53–66.

Article  CAS  PubMed  Google Scholar 

Maas AI, Menon DK, Lingsma HF, Pineda JA, Sandel ME, Manley GT. Re-orientation of clinical research in traumatic brain injury: report of an international workshop on comparative effectiveness research. J Neurotrauma. 2012;29:32–46.

Article  PubMed  PubMed Central  Google Scholar 

Menon DK, Maas AI, Traumatic brain injury in,. Progress, failures and new approaches for TBI research. Nat Rev Neurol. 2014;2015(11):71–2.

Google Scholar 

Omura T, Sato R, Cooper DY, Rosenthal O, Estabrook RW. Function of cytochrome P-450 of microsomes. Fed Proc. 1965;24:1181–9.

CAS  PubMed  Google Scholar 

Goascogne C, Gouézou M, Robel P, Defaye G, Chambaz E, Waterman MR, et al. The cholesterol side-chain cleavage complex in human brain white matter. J Neuroendocrinol. 1989;1:153–6.